Monopar Therapeutics — Director's Dealing 2019

Jan 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Monopar Therapeutics (NONE)
CIK: 0001645469
Period of Report: 2018-12-30

Reporting Person: RIOUX PATRICE (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-30	Stock option	$6	A	20000	Acquired	2028-12-30	Common stock (20000)	Direct

Footnotes

F1: Stock options vest and become exercisable according to the following schedule: 1,667 shares vest on January 31, 2019 and the last day of each subsequent month thereafter.